World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
78
Citations
21083
World Ranking
1757
National Ranking
153

Lucy R. Wedderburn publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lucy R. Wedderburn sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 467 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lucy R. Wedderburn D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lucy R. Wedderburn sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 78 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lucy R. Wedderburn is affiliated with University College London in the United Kingdom. Their main field of study is Medicine, with a focus on several subfields including Hematology, Epidemiology, Immunology, Rheumatology, and Infectious Diseases.

The scientist's research explores a range of topics, notably autoimmune and inflammatory disorders, inflammatory myopathies and dermatomyositis, adolescent and pediatric healthcare, immunodeficiency and autoimmune disorders, acute lymphoblastic leukemia, COVID-19 clinical research studies, and celiac disease research and management.

Recent significant publications include:

  • Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission, 2020, Nature Communications
  • Preexisting and de novo humoral immunity to SARS-CoV-2 in humans, 2020, Science
  • Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells, 2020, Cell Metabolism
  • Biological classification of childhood arthritis: roadmap to a molecular nomenclature, 2021, Nature Reviews Rheumatology
  • Diapedesis-Induced Integrin Signaling via LFA-1 Facilitates Tissue Immunity by Inducing Intrinsic Complement C3 Expression in Immune Cells, 2020, Immunity

Frequent co-authors collaborating with Wedderburn include:

  • Kimme L Hyrich
  • Coziana Ciurtin
  • Elizabeth C. Rosser
  • Melissa Kartawinata
  • Claire T. Deakin

Their work is often published in venues such as:

  • Lara D. Veeken
  • Annals of the Rheumatic Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Rheumatology Advances in Practice
  • Nature Reviews Rheumatology

Best Publications

  • Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

    Kevin W. Ng;Nikhil Faulkner;Georgina H. Cornish;Annachiara Rosa

  • CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis

    Ismé M. de Kleer;Lucy R. Wedderburn;Leonie S. Taams;Alka Patel

  • Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells

    Elizabeth C. Rosser;Elizabeth C. Rosser;Christopher J.M. Piper;Diana E. Matei;Paul A. Blair

  • Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment.

    Kiran Nistala;Stuart Adams;Helen Cambrook;Simona Ursu

  • Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis

    Anne Hinks;Anne Hinks;Joanna E. Cobb;Joanna E. Cobb;Miranda C. Marion;Sampath Prahalad

  • Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers.

    Kiran Nistala;Halima Moncrieffe;Katy R Newton;Hemlata Varsani

  • Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study

    Wilco de Jager;Esther P A H Hoppenreijs;Nico M Wulffraat;Lucy R Wedderburn

  • The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)—clinical characteristics of children recruited within the first 5 yr

    L J McCann;A D Juggins;S M Maillard;L R Wedderburn

  • T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria.

    Hilton C. Whittle;Jim Brown;Kevin Marsh;Brian M. Greenwood

  • Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis

    Kiran Nistala;Lucy R Wedderburn

  • Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosis

    Harsha Gunawardena;L R Wedderburn;H Chinoy;Zoe E Betteridge

  • Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis

    S M Maillard;R Jones;C Owens;C Pilkington

  • Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis.

    Lucy R. Wedderburn;Nicola Robinson;Alka Patel;Hemlata Varsani

  • Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.

    H. Gunawardena;L. R. Wedderburn;J. North;Z. Betteridge

  • Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis

    A T Chan;S D Kollnberger;L R Wedderburn;P Bowness

  • Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

    Sarah L Tansley;Zoe E Betteridge;Harsha Gunawardena;Thomas S Jacques

  • The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis

    Dirk Holzinger;Michael Frosch;Astrid Kastrup;Femke H M Prince

  • Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.

    Sarah L. Tansley;Sarah L. Tansley;Stefania Simou;Gavin Shaddick;Zoe E. Betteridge

  • HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

    Michael J. Ombrello;Elaine F. Remmers;Ioanna Tachmazidou;Alexei Grom;Alexei Grom

  • Structural and Functional Insights of RANKL–RANK Interaction and Signaling

    Changzhen Liu;Thomas S. Walter;Peng Huang;Shiqian Zhang

  • Clonal Expansions in Acute EBV Infection Are Detectable in the CD8 and not the CD4 Subset and Persist with a Variable CD45 Phenotype

    Mala K. Maini;Nancy Gudgeon;Lucy R. Wedderburn;Alan B. Rickinson

  • Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans

    Kevin Ng;Nikhil Faulkner;Georgina Cornish;Annachiara Rosa

Frequent Co-Authors

Wendy Thomson
Wendy Thomson University of Manchester
Kimme L. Hyrich
Kimme L. Hyrich University of Manchester
Neil McHugh
Neil McHugh University of Bath
Anne Hinks
Anne Hinks University of Manchester
Janice L. Holton
Janice L. Holton University College London
Susan D. Thompson
Susan D. Thompson Cincinnati Children's Hospital Medical Center
Ingrid E. Lundberg
Ingrid E. Lundberg Karolinska University Hospital
Janine A. Lamb
Janine A. Lamb University of Manchester
John F. Bohnsack
John F. Bohnsack University of Utah
Carl D. Langefeld
Carl D. Langefeld Wake Forest University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career from Immunology, nursing presents several accessible paths. Many students begin with an LPN program to build foundational clinical skills. If you’re exploring entry points, check out which lpn programs are easiest to get into to find options that match your pace and background.

For higher clinical responsibilities, nurse practitioner degrees offer great versatility. Those looking for flexible learning can explore the array of easiest online nurse practitioner programs, which cater to busy schedules and diverse learning needs.

If your interest aligns more with mental health, specialized programs like psychiatric-mental health nurse practitioner (PMHNP) degrees provide focused training. To optimize clinical experience, consider the best online pmhnp programs with best clinical placement rates, designed to support real-world training efficiently.

Cost-efficiency is another factor to consider. Affordable education options such as the cheapest pmhnp certificate programs enable learners to advance their qualifications without excessive financial burden.

Best Scientists Citing Lucy R. Wedderburn

Trending Scientists

Recently Published Articles